M&A revival with a 71% increase in billion-dollar transactions in Q1 2024

Mergers and acquisitions (M&As) in the biopharmaceutical industry involving companies developing drugs showed a 20% increase in total deal volume in the first quarter (Q1) of 2024 compared to Q1 2023, according to leading data and analytics company GlobalData’s Pharma Intelligence Center Deals Database.

May 3, 2024 - 00:00

M&A revival with a 71% increase in billion-dollar transactions in Q1 2024

Mergers and acquisitions (M&As) in the biopharmaceutical industry involving companies developing drugs showed a 20% increase in total deal volume in the first quarter (Q1) of 2024 compared to Q1 2023, according to leading data and analytics company GlobalData’s Pharma Intelligence Center Deals Database.

Read the original article

Tags:

Previous Article

Emergent cuts 300 jobs and shuts down two facilities in cost-cutting drive

Vertex Pharmaceuticals gets grant for treatment of alpha-1 antitrypsin deficienc...

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

STAT+: The high hopes — and high stakes — behind Microsoft and Epic’s plan to use AI to answer patient questions

STAT+: The high hopes — and high stakes — behind Micros...

Apr 21, 2023

FDA approves Pfizer’s RSV vaccine designed to protect newborns by immunizing parent

FDA approves Pfizer’s RSV vaccine designed to protect n...

Aug 21, 2023

More than 1 billion people have obesity, including 159 million young people, study estimates

More than 1 billion people have obesity, including 159 ...

Feb 29, 2024